1. Campbell AW, et al. Mold and mycotoxins: effects on the neurological and immune systems in humans. Adv Appl Microbiol. 2004;55:375.

2. Brewer JH, Thrasher JD, Hooper D. Chronic illness associated with mold and mycotoxins: is naso-sinus fungal biofilm the culprit? Toxins. 2014;6(1):66-80.

3. Hope, Janette. Complete evaluation of mold exposed patients and their environments. Lecture presented: AAEM Dallas 2018.

4. Boonen J, et al. Human skin penetration of selected model mycotoxins. Toxicology. 2012;301(1-3):21-32.

5. Storey E, et al. Guidance for clinicians on the recognition and management of health effects related to mold exposure and moisture indoors. University of Connecticut Health Center. 2004.

6. Visual Contrast Sensitivity Test. VCSTest.com website. https://www.vcstest.com/ Accessed February 2018.

7. US Environmental Protection Agency. 1989. Report to Congress on indoor air quality: Volume II – Assessment and Control of Indoor Air Pollution. Washington, DC. EPA Office of Air and Radiation; 1989. EPA/400/1-89/001C. https://nepis.epa.gov/Exe/ZyPURL.cgi?Dockey=9100LMBU.TXT. Accessed February 2018.

8. Federal Emergency Management Agency. Dealing With Mold & Mildew in Your Flood Damaged Home. https://www.fema.gov/pdf/rebuild/recover/fema_mold_brochure_english.pdf. Accessed February, 2018.

9. Brunekreef B, et al. Home dampness and respiratory morbidity in children. Am Rev Respir Dis, 1989;140(5): 1363-7

10. Maier, WC, et al. Indoor risk factors for asthma and wheezing among Seattle school children. Environ Health Perspect, 1997;105(2): 208-14.

11. Spengler J, et al. Respiratory symptoms and housing characteristics. Indoor Air, 1994;4:72-82.

12. Stark PC, et al. Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Care Med. 2003;168(2): 232-7.

13. Prevalence of Building Dampness. Lawrence Berkeley National Laboratory Indoor Environment Group website. https://iaqscience.lbl.gov/dampness-prevalence. Accessed February 2018.

14. United States Department of Agriculture. Molds on Food: Are They Dangerous? Food Safety and Inspection Service; 2013.

15. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16(3): 497-516.

16. Brandt ME, Lockhart SR, Warnock DW. Laboratory aspects of medical mycology. In: Kauffman C, Pappas P, Sobel J, Dismukes W, (eds). Essentials of Clinical Mycology. New York: Springer; 2003:1–22.

17. Bbosa GS, Kitya D, Lubega A, et al. Review of the Biological and Health Effects of Aflatoxins on Body Organs and Body Systems, Aflatoxins - Recent Advances and Future Prospects. 2013.

18. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol. 1985;18(5):574-82.

19. Valdes JJ, Cameron JE, Cole RJ. Aflatrem: a tremorgenic mycotoxin with acute neurotoxic effects. Environ Health Perspect. 1985;62:459-63.

20. Dutton ME. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol Ther. 1996;70(2):137-61.

21. Doi K, Uetsuka K. Mechanisms of Mycotoxin-Induced Neurotoxicity through Oxidative Stress-Associated Pathways. International Journal of Molecular Science. 2011; 12(8): 5213–5237

22. Thrasher JD, Crawley S. The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes. Toxicol Ind Health. 2009;25(9-10):583-615.

23. Case Definition: Trichothecene Mycotoxin. Centers for Disease Control and Prevention website. https://emergency.cdc.gov/agent/trichothecene/casedef.asp.

24. Bui-Klimke TR. Wu F. Ochratoxin A and human health risk: a review of the evidence. Crit Rev Food Sci Nutr. 2015; 55(13):1860-9.

25. Brewer JH, Thrasher JD, Straus DC, et al. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins. 2013;5(4):605-617.

26. Iordonov MS, et al. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cel Biol. 1997;17(6): 3373-81.

27. Crago BR, et al. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Arch Environ Health. 2003;58(8):452-63. 31.

28. Karunasena E, et al. Building-associated neurological damage modeled in human cells: a mechanism of neurotoxic effects by exposure to mycotoxins in the indoor environment. Mycopathologia. 2010;170(6):377-90.

29. Sava V, et al. Can low level exposure to ochratoxin-A cause parkinsonism? J Neurol Sci. 2006;249(1):68-75.

30. Bredesen, DE. Inhalational Alzheimer’s disease: an unrecognized – and treatable – epidemic. Aging. 2016;8(2):304-313.

31.Hope J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. The Scientific World Journal. 2013.